Table 2 Anthropometric and biochemical measures according to the metabolic obesity phenotypes in a cross sectional study of Hoveyzeh Cohort

Fasting blood sugar (mg/dl)

94.72 ± 28.57 ^{a, b, c}

125.51 ± 60.30 ^{d, e}

89.74 ± 6.80 ^f

Triglycerides (mg/dl)

109.67 ± 51.79 ^{a, c}

197.65 ± 131.37 ^{d, e}

104.27 ± 29.38 ^f

Total Cholesterol (mg/dl)

182.25 ± 36.84 ^{a, b, c}

192.36 ± 43.49

188.59 ± 31.04

High-density lipoprotein (mg/dl)

54.89 ± 11.91 ^{a, b, c}

46.63 ± 11.01 ^{d, e}

57.51 ± 10.15 ^f

Low-density lipoprotein (mg/dl)

105.40 ± 31.48 ^b

106.95 ± 34.82

110.06 ± 27.56

Aspartate transaminase (U/L)

18.47 ± 7.82

18.61 ± 11.07

17.55 ± 6.68

Alanine aminotransferase (U/L)

18.72 ± 12.94 ^{a, c}

22.03 ± 15.30 ^d

19.44 ± 13.78 ^f

Alkaline phosphatase (U/L)

199.37 ± 59.25 ^{a, c}

219.29 ± 62.41 ^d

199.71 ± 59.59 ^f

Waist-To-Hip Ratio

0.91 ± 0.06 ^{a, b, c}

0.97 ± 0.06 ^{d, e}

0.95 ± 0.07 ^f

Waist-To-Height Ratio

0.54 ± 0.05 ^{a, b, c}

0.59 ± 0.05 ^{d, e}

0.66 ± 0.06 ^f

Body mass index

24.39 ± 2.91 ^{a, b, c}

26.59 ± 2.45 ^{d, e}

33.58 ± 2.99 ^f

Body Adiposity Index

28.24 ± 4.88 ^{a, b, c}

29.02 ± 4.27 ^{d, e}

37.42 ± 5.04 ^f

Visceral Adiposity Index

1.40 ± 0.70 ^{a, c}

3.16 ± 2.53 ^{d, e}

1.33 ± 0.43 ^f

Weight-adjusted Waist Index

10.95 ± 0.81 ^{a, b, c}

11.40 ± 0.82 ^e

11.48 ± 0.78 ^f